Effects of atorvastatin on release of endothelial microparticles and myocardial apoptosis in rats with acute myocardial infarction
LI Qiang1, GUO Zhuang-bo1, WU Guang-ying1, LI Chao-xia2, ZHONG Zhi-yong3
1. Department of Emergency, Guangzhou Red Cross Hospital, the Fourth Affiliated Hospital, School of Medicine, Jinan University, Guangzhou 510220, China;
2. Clinical Laboratory, Guangzhou Red Cross Hospital, the Fourth Affiliated Hospital, School of Medicine, Jinan University, Guangzhou 510220, China;
3. Medical Laboratory Animal Center of Guangdong Province, Foshan 528248, China
AIM: To investigate the effect of atorvastatin(AT) on the release of endothelial microparticles(EMP) and myocardial apoptosis in the rats with myocardial infarction. METHODS: SD male rats(n=24) were randomly divided into 3 groups:sham operation(sham) group, myocardial infarction(MI) group and MI+AT group. The rat model of acute myocardial infarction was prepared by coronary artery ligation. At 2 h and 24 h after modeling, the peripheral blood was collected to detect creatine kinase-MB(CK-MB) and cardiac troponin T(cTnT). The circulating levels of EMP were measured by flow cytometry. The myocardial apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling(TUNEL) assay. RESULTS: At 2 h after modeling, the level of CK-MB was significantly increased in MI group compared with sham group, and the level of EMP and the myocardial apoptotic rate were significantly increased in MI group and MI+AT group compared with sham group. At 24 h after modeling, the level of EMP was significantly increased in MI group compared with sham group. The levels of CK-MB, cTnT, EMP and the myocardial apoptotic rate were significantly decreased in MI+AT group compared with MI group. Moreover, the level of CK-MB in MI group was significantly increased at 24 h compared with that at 2 h after modeling. The levels of CK-MB, cTnT and EMP were significantly decreased in MI+AT group at 24 h compared with those at 2 h after modeling. CONCLUSION: Ator-vastatin may reduce the level of EMP and the myocardial apoptotic rate in the rats with acute myocardial infarction, indicating that atorvastatin plays a role in protecting endothelium.
Tawfik MK, Ghattas MH, Abo-Elmatty DM, et al. Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2010, 14(6):499-506.
[2]
Lacroix R, Robert S, Poncelet P, et al.Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads:results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop[J]. J Thromb Haemost, 2010,8(11):2571-2574.
[3]
Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes[J]. Am Heart J, 2003, 145(6):962-970.
[4]
Jung C, Sörensson P, Saleh N, et al. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocar-dial infarction[J]. Atherosclerosis, 2012, 221(1):226-231.
Pirro M, Schillaci G, Bagaglia F, et al. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk[J]. Atherosclerosis, 2008, 197(2):757-767.
[8]
Inzhutova AI, Larionov AA, Petrova MM, et al. Stabilization of cellular membranes as a target of vascular therapy[J]. Kardiologiia, 2011, 51(4):52-55.
Sadowitz B, Maier KG, Gahtan V. Basic science review:Statin therapy——Part I:the pleiotropic effects of statins in cardiovascular disease[J]. Vasc Endovascular Surg, 2010, 44(4):241-251.
[11]
Swenne CA. Beyond lipid lowering:pleiotropic effects of statins in heart failure[J]. Neth Heart J, 2013, 21(9):406-407.
[12]
Curtis AM, Zhang L, Medenilla E, et al. Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population[J]. Cytometry B Clin Cytom, 2010,78(5):329-337.
[13]
Landmesser U, Engberding N, Bahlmann FH, et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase[J]. Circulation, 2004, 110(14):1933-1939.
[14]
Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention:results of the ARMYDA-RECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trial[J]. J Am Coll Cardiol, 2009, 54(6):558-565.
[15]
Sun H, Guo T, Liu L, et al. Ischemic postconditioning inhibits apoptosis after acute myocardial infarction in pigs[J]. Heart Surg Forum, 2010, 13(5):305-310.
[16]
Bäcklund T, Palojoki E, Saraste A,et al. Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes[J]. Diabetologia, 2004, 47(2):325-330.
[17]
GuoY, He J, Wu J, et al. Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis[J]. Arch Med Res, 2008, 39(2):179-188.
Matsue Y, Suzuki M, Nagahori W, et al. Endothelial dysfunction measured by peripheral arterial tonometry predicts prognosis in patients with heart failure with preserved ejection fraction[J]. Int J Cardiol, 2013,168(1):36-40.
